Aleve Has A ‘Headache’ For Proprietary Brand And As First Indication On Labeled Uses List
Executive Summary
US FDA approves Bayer HealthCare's supplemental NDA for adding Aleve Headache Pain proprietary name to use with the brand’s regular strength formulation, naproxen 220 mg. The approval also allows moving headache to top of indications list.